Burtin P, Chany E, Beaulieu R, Maunoury M T, Chavanel G, Sabine M C
Cancer. 1977 Jun;39(6):2378-85. doi: 10.1002/1097-0142(197706)39:6<2378::aid-cncr2820390611>3.0.co;2-v.
Crude extracts of colorectal surgical tumors, either individual or pooled, and HT29 line cells were compared in leucocyte migration inhibition test. HT29 cell extract gave more positive reactions with leucocytes of colorectal cancer patients than the other ones, and less with control leucocytes. It was thus used for all the subsequent experiments. As a whole, we obtained 44% (30/68) of positive inhibitions in patients afflicted with a colorectal carcinoma, against 9% (3/31e in normal controls and 20% (8/40) in patients bearing a carcinoma from another organ. Among the latest patients, those having a gynecological carcinoma were rarely positive, contrasting with those suffering from a carcinoma from the aerodigestive organs. It seemed that the antigen(s) involved in the reaction had no organ specificity, but rather a broad tissue specificity.
在白细胞迁移抑制试验中,对结直肠手术肿瘤的粗提物(单个或混合)以及HT29细胞系进行了比较。HT29细胞提取物与结直肠癌患者的白细胞产生的阳性反应比其他提取物更多,而与对照白细胞产生的阳性反应较少。因此,它被用于所有后续实验。总体而言,我们在患有结直肠癌的患者中获得了44%(30/68)的阳性抑制率,而在正常对照中为9%(3/31),在患有其他器官癌症的患者中为20%(8/40)。在最后一组患者中,患有妇科癌症的患者很少呈阳性,这与患有气消化道器官癌症的患者形成对比。似乎参与该反应的抗原没有器官特异性,而是具有广泛的组织特异性。